These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470. Devineni D; Klein-Szanto A; Gallo JM Cancer Res; 1996 May; 56(9):1983-7. PubMed ID: 8616836 [TBL] [Abstract][Full Text] [Related]
23. Preclinical pharmacokinetic and pharmacodynamic evaluation of metronomic and conventional temozolomide dosing regimens. Zhou Q; Guo P; Wang X; Nuthalapati S; Gallo JM J Pharmacol Exp Ther; 2007 Apr; 321(1):265-75. PubMed ID: 17259446 [TBL] [Abstract][Full Text] [Related]
24. Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98). Broniscer A; Iacono L; Chintagumpala M; Fouladi M; Wallace D; Bowers DC; Stewart C; Krasin MJ; Gajjar A Cancer; 2005 Jan; 103(1):133-9. PubMed ID: 15565574 [TBL] [Abstract][Full Text] [Related]
25. Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy. Dong Y; Feng SS Int J Pharm; 2007 Sep; 342(1-2):208-14. PubMed ID: 17560058 [TBL] [Abstract][Full Text] [Related]
26. Preparation of curcumin loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanofibers and their in vitro antitumor activity against Glioma 9L cells. Guo G; Fu S; Zhou L; Liang H; Fan M; Luo F; Qian Z; Wei Y Nanoscale; 2011 Sep; 3(9):3825-32. PubMed ID: 21847493 [TBL] [Abstract][Full Text] [Related]
27. Acquisition of resistance to antitumor alkylating agent ACNU: a possible target of positron emission tomography monitoring. Kawai H; Toyohara J; Kado H; Nakagawa T; Takamatsu S; Furukawa T; Yonekura Y; Kubota T; Fujibayashi Y Nucl Med Biol; 2006 Jan; 33(1):29-35. PubMed ID: 16459256 [TBL] [Abstract][Full Text] [Related]
28. Poly(ethylene glycol)-block-poly(2-methyl-2-benzoxycarbonyl-propylene carbonate) micelles for rapamycin delivery: in vitro characterization and biodistribution. Lu W; Li F; Mahato RI J Pharm Sci; 2011 Jun; 100(6):2418-29. PubMed ID: 21264854 [TBL] [Abstract][Full Text] [Related]
29. Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy. Murphy PS; Viviers L; Abson C; Rowland IJ; Brada M; Leach MO; Dzik-Jurasz AS Br J Cancer; 2004 Feb; 90(4):781-6. PubMed ID: 14970853 [TBL] [Abstract][Full Text] [Related]
30. Antifolate activity of pyrimethamine enhances temozolomide-induced cytotoxicity in melanoma cells. Chen M; Osman I; Orlow SJ Mol Cancer Res; 2009 May; 7(5):703-12. PubMed ID: 19435820 [TBL] [Abstract][Full Text] [Related]
31. Ultrafine PEG-PLA fibers loaded with both paclitaxel and doxorubicin hydrochloride and their in vitro cytotoxicity. Xu X; Chen X; Wang Z; Jing X Eur J Pharm Biopharm; 2009 May; 72(1):18-25. PubMed ID: 19027067 [TBL] [Abstract][Full Text] [Related]
33. Erythropoietin augments survival of glioma cells after radiation and temozolomide. Hassouna I; Sperling S; Kim E; Schulz-Schaeffer W; Rave-Fränk M; Hasselblatt M; Jelkmann W; Giese A; Ehrenreich H Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):927-34. PubMed ID: 19014782 [TBL] [Abstract][Full Text] [Related]
34. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model. Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548 [TBL] [Abstract][Full Text] [Related]
35. [Central nervous system glioma. Multi-drug chemotherapy including temozolomide]. Wakabayashi T Gan To Kagaku Ryoho; 2009 Jun; 36(6):938-40. PubMed ID: 19579330 [No Abstract] [Full Text] [Related]
36. Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft. Patel VJ; Elion GB; Houghton PJ; Keir S; Pegg AE; Johnson SP; Dolan ME; Bigner DD; Friedman HS Clin Cancer Res; 2000 Oct; 6(10):4154-7. PubMed ID: 11051270 [TBL] [Abstract][Full Text] [Related]
37. Non-sufficient cell cycle control as possible clue for the resistance of human malignant glioma cells to clinically relevant treatment conditions. Trog D; Moenkemann H; Breipohl W; Schueller H; Schild H; Golubnitschaja O Amino Acids; 2007; 32(3):373-9. PubMed ID: 17077962 [TBL] [Abstract][Full Text] [Related]
38. Biocompatibility evaluation of electrospun aligned poly (propylene carbonate) nanofibrous scaffolds with peripheral nerve tissues and cells in vitro. Wang Y; Zhao Z; Zhao B; Qi HX; Peng J; Zhang L; Xu WJ; Hu P; Lu SB Chin Med J (Engl); 2011 Aug; 124(15):2361-6. PubMed ID: 21933569 [TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery. Alipour S; Montaseri H; Tafaghodi M Colloids Surf B Biointerfaces; 2010 Dec; 81(2):521-9. PubMed ID: 20732796 [TBL] [Abstract][Full Text] [Related]